BMA: vaccine ‘breakthrough’ brings ‘widespread protection a step closer’
First interim analysis from phase 3 study finds vaccine candidate against COVID-19 to be 90% effective.
Published
Please sign in or register for FREE
Sign in to OnMedica
Or sign in via
Are you a GP or Specialist Doctor, practising in UK, looking for:
- easy-to-digest, relevant updates and educational content
- a safe-space to share and collaborate with peers?
OnMedica is for you, sign up FOR FREE now!
No comments yet.